• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC 2.46% $1.19

RACE ONCOLOGY LTD - Announcements

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a... Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.More

Recently Updated

Corporate Spotlight

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight arrow Created with Sketch.

Announcements


Filters [Clear]
  • Price Sensitive: Yes
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE18/04/24 download Created with Sketch. 479.94KB
RAC RC220 cGMP Manufacturing CompletePRICE SENSITIVE26/03/24 download Created with Sketch. 315.62KB
RAC Bisantrene shows potent anticancer activity in AML modelsPRICE SENSITIVE06/03/24 download Created with Sketch. 856.44KB
RAC S&P DJI Announces March 2024 Quarterly RebalancePRICE SENSITIVE01/03/24 download Created with Sketch. 120.24KB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE28/02/24 download Created with Sketch. 4.3MB
RAC Race Receives $4.0m R&D Tax Refund for Financial Year 2023PRICE SENSITIVE27/02/24 download Created with Sketch. 264.05KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE30/01/24 download Created with Sketch. 628.97KB
RAC December 2023 Preclinical & Clinical Program UpdatePRICE SENSITIVE29/12/23 download Created with Sketch. 352.32KB
RAC Bonus Options ProspectusPRICE SENSITIVE22/11/23 download Created with Sketch. 393.29KB
RAC Updated Strategy and Investor PresentationPRICE SENSITIVE22/11/23 download Created with Sketch. 2.05MB
RAC Dr Daniel Tillett appointed CEO of Race OncologyPRICE SENSITIVE22/11/23 download Created with Sketch. 302.46KB
RAC RC220 Meets Quality SpecificationsPRICE SENSITIVE09/11/23 download Created with Sketch. 327.14KB
RAC Impressive Bisantrene Phase 2 AML Clinical ResultsPRICE SENSITIVE06/11/23 download Created with Sketch. 937.9KB
RAC Trading HaltPRICE SENSITIVE03/11/23 download Created with Sketch. 349KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE23/10/23 download Created with Sketch. 483.58KB
RAC RC220 Peripheral Infusion Safety ConfirmedPRICE SENSITIVE17/10/23 download Created with Sketch. 294.3KB
RAC RC220 Toxicology and Safety Pharmacology Studies InitiatedPRICE SENSITIVE05/10/23 download Created with Sketch. 299.18KB
RAC Bisantrene cGMP API Manufacturing Completed at Laurus LabsPRICE SENSITIVE27/09/23 download Created with Sketch. 301.44KB
RAC Bisantrene Shows Broad Anti-Cancer Activity in Cancer CellsPRICE SENSITIVE21/09/23 download Created with Sketch. 322.24KB
RAC Appendix 4E & Annual ReportPRICE SENSITIVE30/08/23 download Created with Sketch. 1.73MB
RAC Race Board and Management Team ChangesPRICE SENSITIVE22/08/23 download Created with Sketch. 303.9KB
RAC Race Strategic Update August 2023PRICE SENSITIVE08/08/23 download Created with Sketch. 5.62MB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE31/07/23 download Created with Sketch. 325.58KB
RAC Race Receives Additional $1.66m R&D Tax Refund for FY 2022PRICE SENSITIVE13/07/23 download Created with Sketch. 98.17KB
RAC Race executes agreement with Ardena for GMP manufacturingPRICE SENSITIVE12/07/23 download Created with Sketch. 103.46KB
RAC Race global agreement with City of Hope to access FTO IPPRICE SENSITIVE10/07/23 download Created with Sketch. 136.17KB
RAC H1 2023 Preclinical and Clinical Programs UpdatePRICE SENSITIVE07/07/23 download Created with Sketch. 186.32KB
RAC Letter to ShareholdersPRICE SENSITIVE15/06/23 download Created with Sketch. 96.85KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/04/23 download Created with Sketch. 423.96KB
RAC Race releases complete cardio-protection data & videoPRICE SENSITIVE14/04/23 download Created with Sketch. 3.13MB
RAC Race releases cardioprotection market potential dataPRICE SENSITIVE04/04/23 download Created with Sketch. 615.57KB
RAC Race Receives $1.48m R&D Tax Refund for Financial Year 2022PRICE SENSITIVE27/03/23 download Created with Sketch. 81.67KB
RAC Race Leadership ChangesPRICE SENSITIVE24/03/23 download Created with Sketch. 107.25KB
RAC Trading HaltPRICE SENSITIVE22/03/23 download Created with Sketch. 217.33KB
RAC Pause in TradingPRICE SENSITIVE22/03/23 download Created with Sketch. 115.29KB
RAC Race Executes Contracts to Commence Breast Cancer TrialPRICE SENSITIVE13/03/23 download Created with Sketch. 128.41KB
RAC New Collaboration to Understand Zantrene CardioprotectionPRICE SENSITIVE02/03/23 download Created with Sketch. 110.53KB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE27/02/23 download Created with Sketch. 745.76KB
RAC Race Receives Cardioprotection Ethics Trial ApprovalPRICE SENSITIVE01/02/23 download Created with Sketch. 126.08KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE31/01/23 download Created with Sketch. 335.85KB
RAC Race supports Study of Extramedullary AMLPRICE SENSITIVE22/12/22 download Created with Sketch. 167.5KB
RAC Race Appoints Damian Clarke-Bruce as CEO & Managing DirectorPRICE SENSITIVE14/12/22 download Created with Sketch. 127.41KB
RAC Positive Pre-IND Guidance from FDA on ZantrenePRICE SENSITIVE23/11/22 download Created with Sketch. 101.59KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE27/10/22 download Created with Sketch. 377.64KB
RAC Response to ASX Price QueryPRICE SENSITIVE18/10/22 download Created with Sketch. 248.77KB
RAC Race Develops Improved IV Formulation of ZantrenePRICE SENSITIVE28/09/22 download Created with Sketch. 124.87KB
RAC Race Initiates New Drug Discovery ProgramPRICE SENSITIVE27/09/22 download Created with Sketch. 111.39KB
RAC Appendix 4E & Annual ReportPRICE SENSITIVE26/08/22 download Created with Sketch. 1.75MB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE22/07/22 download Created with Sketch. 382.73KB
RAC Zantrene Protects Mouse Hearts from Chemotherapy DamagePRICE SENSITIVE30/06/22 download Created with Sketch. 1.4MB
RAC Zantrene shows synergy with kinase inhibitors in melanomaPRICE SENSITIVE28/06/22 download Created with Sketch. 1.79MB
RAC Zantrene Improves Immune Therapy Treatment of MelanomaPRICE SENSITIVE22/06/22 download Created with Sketch. 1014.98KB
RAC Race Oncology Announces On-Market Share BuybackPRICE SENSITIVE09/06/22 download Created with Sketch. 91.49KB
RAC EMD AML MDS Trial Expands to EuropePRICE SENSITIVE08/06/22 download Created with Sketch. 362.22KB
RAC Zantrene AML trial in Israel advances to Phase 2PRICE SENSITIVE27/05/22 download Created with Sketch. 196.95KB
RAC Trading HaltPRICE SENSITIVE26/05/22 download Created with Sketch. 545.91KB
RAC Pause in TradingPRICE SENSITIVE26/05/22 download Created with Sketch. 115.78KB
RAC Race Receives Governance Approval for AML EMD & MDS TrialPRICE SENSITIVE12/05/22 download Created with Sketch. 158.97KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE21/04/22 download Created with Sketch. 383.15KB
RAC Race receives Human Ethics AML Trial ApprovalPRICE SENSITIVE06/04/22 download Created with Sketch. 174.68KB
RAC Supply Agreement for EMD AML TrialPRICE SENSITIVE30/03/22 download Created with Sketch. 111.72KB
RAC Zantrene highly effective in EMD AML Mouse ModelPRICE SENSITIVE17/03/22 download Created with Sketch. 1.42MB
RAC Compelling Zantrene Preclinical Kidney Cancer DataPRICE SENSITIVE10/03/22 download Created with Sketch. 1.79MB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE25/02/22 download Created with Sketch. 908.64KB
RAC MD Anderson Preclinical AML Study on Zantrene PublishedPRICE SENSITIVE23/02/22 download Created with Sketch. 97.94KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/01/22 download Created with Sketch. 597.56KB
RAC Race raises $29.7 million in oversubscribed SPPPRICE SENSITIVE21/12/21 download Created with Sketch. 102.65KB
RAC Expanded Heart Protection Discovery for ZantrenePRICE SENSITIVE08/12/21 download Created with Sketch. 478.7KB
RAC Race Oncology Investor Presentation - November 2021PRICE SENSITIVE23/11/21 download Created with Sketch. 9.02MB
RAC Race Oncology Share Purchase PlanPRICE SENSITIVE23/11/21 download Created with Sketch. 83.88KB
RAC AGM PresentationsPRICE SENSITIVE23/11/21 download Created with Sketch. 3.19MB
RAC Trading HaltPRICE SENSITIVE23/11/21 download Created with Sketch. 225.88KB
RAC Breakthrough Zantrene Heart Protection DiscoveryPRICE SENSITIVE22/11/21 download Created with Sketch. 1.24MB
RAC University of Wollongong R&D CollaborationPRICE SENSITIVE09/11/21 download Created with Sketch. 121.33KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE28/10/21 download Created with Sketch. 374.46KB
RAC Race secures sixth US patent for ZantrenePRICE SENSITIVE19/10/21 download Created with Sketch. 63.01KB
RAC Race secures fifth US patent for ZantrenePRICE SENSITIVE06/10/21 download Created with Sketch. 60.34KB
RAC Preclinical & Clinical Programs UpdatePRICE SENSITIVE30/09/21 download Created with Sketch. 71.09KB
RAC Zantrene highly effective in Melanoma preclinical studyPRICE SENSITIVE30/09/21 download Created with Sketch. 827.42KB
RAC Appendix 4E & Annual ReportPRICE SENSITIVE26/08/21 download Created with Sketch. 4.99MB
RAC First Patient Dosed in Phase 1b/2 AML TrialPRICE SENSITIVE09/08/21 download Created with Sketch. 117.45KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/07/21 download Created with Sketch. 314.92KB
RAC Race executes Israel AML Phase 2 Trial ContractPRICE SENSITIVE22/06/21 download Created with Sketch. 137.91KB
RAC Race Executes Key Contract for Israel Phase 2 AML TrialPRICE SENSITIVE08/06/21 download Created with Sketch. 59.49KB
RAC Contract to Commence Phase 2 Extramedullary AML TrialPRICE SENSITIVE02/06/21 download Created with Sketch. 122.87KB
RAC ProspectusPRICE SENSITIVE05/05/21 download Created with Sketch. 420.89KB
RAC Race investor briefing & updated presentationPRICE SENSITIVE05/05/21 download Created with Sketch. 7.51MB
RAC Placement closes oversubscribed-Bonus Option Issue launchedPRICE SENSITIVE05/05/21 download Created with Sketch. 333.71KB
RAC Trading HaltPRICE SENSITIVE03/05/21 download Created with Sketch. 181.01KB
RAC Race Initiates Heart Safety Preclinical Study for BisantrenePRICE SENSITIVE28/04/21 download Created with Sketch. 313.1KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE27/04/21 download Created with Sketch. 222.27KB
RAC Second independent study shows Bisantrene inhibits FTOPRICE SENSITIVE15/04/21 download Created with Sketch. 106.83KB
RAC Race Strategic Update March 2021PRICE SENSITIVE31/03/21 download Created with Sketch. 248.9KB
RAC Race Initiates Extramedullary AML Preclinical StudyPRICE SENSITIVE30/03/21 download Created with Sketch. 112.93KB
RAC Race Initiates FTO Directed Kidney Cancer Preclinical StudyPRICE SENSITIVE25/03/21 download Created with Sketch. 111.89KB
RAC Race Initiates FTO Melanoma Preclinical StudyPRICE SENSITIVE19/03/21 download Created with Sketch. 114.1KB
RAC S&P DJI Announces March 2021 Quarterly RebalancePRICE SENSITIVE12/03/21 download Created with Sketch. 183.24KB
RAC Compelling Preclinical Breast Cancer ResultsPRICE SENSITIVE09/03/21 download Created with Sketch. 1.27MB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE25/02/21 download Created with Sketch. 972.04KB
RAC Quarterly Activity Report & Appendix 4CPRICE SENSITIVE27/01/21 download Created with Sketch. 242.62KB
RAC Quarterly Activity Report & Appendix 4C
18/04/24PRICE SENSITIVE download Created with Sketch. 479.94KB
RAC RC220 cGMP Manufacturing Complete
26/03/24PRICE SENSITIVE download Created with Sketch. 315.62KB
RAC Bisantrene shows potent anticancer activity in AML models
06/03/24PRICE SENSITIVE download Created with Sketch. 856.44KB
RAC S&P DJI Announces March 2024 Quarterly Rebalance
01/03/24PRICE SENSITIVE download Created with Sketch. 120.24KB
RAC Appendix 4D & Half-Year Financial Statements
28/02/24PRICE SENSITIVE download Created with Sketch. 4.3MB
RAC Race Receives $4.0m R&D Tax Refund for Financial Year 2023
27/02/24PRICE SENSITIVE download Created with Sketch. 264.05KB
RAC Quarterly Activity Report & Appendix 4C
30/01/24PRICE SENSITIVE download Created with Sketch. 628.97KB
RAC December 2023 Preclinical & Clinical Program Update
29/12/23PRICE SENSITIVE download Created with Sketch. 352.32KB
RAC Bonus Options Prospectus
22/11/23PRICE SENSITIVE download Created with Sketch. 393.29KB
RAC Updated Strategy and Investor Presentation
22/11/23PRICE SENSITIVE download Created with Sketch. 2.05MB
RAC Dr Daniel Tillett appointed CEO of Race Oncology
22/11/23PRICE SENSITIVE download Created with Sketch. 302.46KB
RAC RC220 Meets Quality Specifications
09/11/23PRICE SENSITIVE download Created with Sketch. 327.14KB
RAC Impressive Bisantrene Phase 2 AML Clinical Results
06/11/23PRICE SENSITIVE download Created with Sketch. 937.9KB
RAC Trading Halt
03/11/23PRICE SENSITIVE download Created with Sketch. 349KB
RAC Quarterly Activity Report & Appendix 4C
23/10/23PRICE SENSITIVE download Created with Sketch. 483.58KB
RAC RC220 Peripheral Infusion Safety Confirmed
17/10/23PRICE SENSITIVE download Created with Sketch. 294.3KB
RAC RC220 Toxicology and Safety Pharmacology Studies Initiated
05/10/23PRICE SENSITIVE download Created with Sketch. 299.18KB
RAC Bisantrene cGMP API Manufacturing Completed at Laurus Labs
27/09/23PRICE SENSITIVE download Created with Sketch. 301.44KB
RAC Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
21/09/23PRICE SENSITIVE download Created with Sketch. 322.24KB
RAC Appendix 4E & Annual Report
30/08/23PRICE SENSITIVE download Created with Sketch. 1.73MB
RAC Race Board and Management Team Changes
22/08/23PRICE SENSITIVE download Created with Sketch. 303.9KB
RAC Race Strategic Update August 2023
08/08/23PRICE SENSITIVE download Created with Sketch. 5.62MB
RAC Quarterly Activity Report & Appendix 4C
31/07/23PRICE SENSITIVE download Created with Sketch. 325.58KB
RAC Race Receives Additional $1.66m R&D Tax Refund for FY 2022
13/07/23PRICE SENSITIVE download Created with Sketch. 98.17KB
RAC Race executes agreement with Ardena for GMP manufacturing
12/07/23PRICE SENSITIVE download Created with Sketch. 103.46KB
RAC Race global agreement with City of Hope to access FTO IP
10/07/23PRICE SENSITIVE download Created with Sketch. 136.17KB
RAC H1 2023 Preclinical and Clinical Programs Update
07/07/23PRICE SENSITIVE download Created with Sketch. 186.32KB
RAC Letter to Shareholders
15/06/23PRICE SENSITIVE download Created with Sketch. 96.85KB
RAC Quarterly Activity Report & Appendix 4C
28/04/23PRICE SENSITIVE download Created with Sketch. 423.96KB
RAC Race releases complete cardio-protection data & video
14/04/23PRICE SENSITIVE download Created with Sketch. 3.13MB
RAC Race releases cardioprotection market potential data
04/04/23PRICE SENSITIVE download Created with Sketch. 615.57KB
RAC Race Receives $1.48m R&D Tax Refund for Financial Year 2022
27/03/23PRICE SENSITIVE download Created with Sketch. 81.67KB
RAC Race Leadership Changes
24/03/23PRICE SENSITIVE download Created with Sketch. 107.25KB
RAC Trading Halt
22/03/23PRICE SENSITIVE download Created with Sketch. 217.33KB
RAC Pause in Trading
22/03/23PRICE SENSITIVE download Created with Sketch. 115.29KB
RAC Race Executes Contracts to Commence Breast Cancer Trial
13/03/23PRICE SENSITIVE download Created with Sketch. 128.41KB
RAC New Collaboration to Understand Zantrene Cardioprotection
02/03/23PRICE SENSITIVE download Created with Sketch. 110.53KB
RAC Appendix 4D & Half-Year Financial Statements
27/02/23PRICE SENSITIVE download Created with Sketch. 745.76KB
RAC Race Receives Cardioprotection Ethics Trial Approval
01/02/23PRICE SENSITIVE download Created with Sketch. 126.08KB
RAC Quarterly Activity Report & Appendix 4C
31/01/23PRICE SENSITIVE download Created with Sketch. 335.85KB
RAC Race supports Study of Extramedullary AML
22/12/22PRICE SENSITIVE download Created with Sketch. 167.5KB
RAC Race Appoints Damian Clarke-Bruce as CEO & Managing Director
14/12/22PRICE SENSITIVE download Created with Sketch. 127.41KB
RAC Positive Pre-IND Guidance from FDA on Zantrene
23/11/22PRICE SENSITIVE download Created with Sketch. 101.59KB
RAC Quarterly Activity Report & Appendix 4C
27/10/22PRICE SENSITIVE download Created with Sketch. 377.64KB
RAC Response to ASX Price Query
18/10/22PRICE SENSITIVE download Created with Sketch. 248.77KB
RAC Race Develops Improved IV Formulation of Zantrene
28/09/22PRICE SENSITIVE download Created with Sketch. 124.87KB
RAC Race Initiates New Drug Discovery Program
27/09/22PRICE SENSITIVE download Created with Sketch. 111.39KB
RAC Appendix 4E & Annual Report
26/08/22PRICE SENSITIVE download Created with Sketch. 1.75MB
RAC Quarterly Activity Report & Appendix 4C
22/07/22PRICE SENSITIVE download Created with Sketch. 382.73KB
RAC Zantrene Protects Mouse Hearts from Chemotherapy Damage
30/06/22PRICE SENSITIVE download Created with Sketch. 1.4MB
RAC Zantrene shows synergy with kinase inhibitors in melanoma
28/06/22PRICE SENSITIVE download Created with Sketch. 1.79MB
RAC Zantrene Improves Immune Therapy Treatment of Melanoma
22/06/22PRICE SENSITIVE download Created with Sketch. 1014.98KB
RAC Race Oncology Announces On-Market Share Buyback
09/06/22PRICE SENSITIVE download Created with Sketch. 91.49KB
RAC EMD AML MDS Trial Expands to Europe
08/06/22PRICE SENSITIVE download Created with Sketch. 362.22KB
RAC Zantrene AML trial in Israel advances to Phase 2
27/05/22PRICE SENSITIVE download Created with Sketch. 196.95KB
RAC Trading Halt
26/05/22PRICE SENSITIVE download Created with Sketch. 545.91KB
RAC Pause in Trading
26/05/22PRICE SENSITIVE download Created with Sketch. 115.78KB
RAC Race Receives Governance Approval for AML EMD & MDS Trial
12/05/22PRICE SENSITIVE download Created with Sketch. 158.97KB
RAC Quarterly Activity Report & Appendix 4C
21/04/22PRICE SENSITIVE download Created with Sketch. 383.15KB
RAC Race receives Human Ethics AML Trial Approval
06/04/22PRICE SENSITIVE download Created with Sketch. 174.68KB
RAC Supply Agreement for EMD AML Trial
30/03/22PRICE SENSITIVE download Created with Sketch. 111.72KB
RAC Zantrene highly effective in EMD AML Mouse Model
17/03/22PRICE SENSITIVE download Created with Sketch. 1.42MB
RAC Compelling Zantrene Preclinical Kidney Cancer Data
10/03/22PRICE SENSITIVE download Created with Sketch. 1.79MB
RAC Appendix 4D & Half-Year Financial Statements
25/02/22PRICE SENSITIVE download Created with Sketch. 908.64KB
RAC MD Anderson Preclinical AML Study on Zantrene Published
23/02/22PRICE SENSITIVE download Created with Sketch. 97.94KB
RAC Quarterly Activity Report & Appendix 4C
28/01/22PRICE SENSITIVE download Created with Sketch. 597.56KB
RAC Race raises $29.7 million in oversubscribed SPP
21/12/21PRICE SENSITIVE download Created with Sketch. 102.65KB
RAC Expanded Heart Protection Discovery for Zantrene
08/12/21PRICE SENSITIVE download Created with Sketch. 478.7KB
RAC Race Oncology Investor Presentation - November 2021
23/11/21PRICE SENSITIVE download Created with Sketch. 9.02MB
RAC Race Oncology Share Purchase Plan
23/11/21PRICE SENSITIVE download Created with Sketch. 83.88KB
RAC AGM Presentations
23/11/21PRICE SENSITIVE download Created with Sketch. 3.19MB
RAC Trading Halt
23/11/21PRICE SENSITIVE download Created with Sketch. 225.88KB
RAC Breakthrough Zantrene Heart Protection Discovery
22/11/21PRICE SENSITIVE download Created with Sketch. 1.24MB
RAC University of Wollongong R&D Collaboration
09/11/21PRICE SENSITIVE download Created with Sketch. 121.33KB
RAC Quarterly Activity Report & Appendix 4C
28/10/21PRICE SENSITIVE download Created with Sketch. 374.46KB
RAC Race secures sixth US patent for Zantrene
19/10/21PRICE SENSITIVE download Created with Sketch. 63.01KB
RAC Race secures fifth US patent for Zantrene
06/10/21PRICE SENSITIVE download Created with Sketch. 60.34KB
RAC Preclinical & Clinical Programs Update
30/09/21PRICE SENSITIVE download Created with Sketch. 71.09KB
RAC Zantrene highly effective in Melanoma preclinical study
30/09/21PRICE SENSITIVE download Created with Sketch. 827.42KB
RAC Appendix 4E & Annual Report
26/08/21PRICE SENSITIVE download Created with Sketch. 4.99MB
RAC First Patient Dosed in Phase 1b/2 AML Trial
09/08/21PRICE SENSITIVE download Created with Sketch. 117.45KB
RAC Quarterly Activity Report & Appendix 4C
29/07/21PRICE SENSITIVE download Created with Sketch. 314.92KB
RAC Race executes Israel AML Phase 2 Trial Contract
22/06/21PRICE SENSITIVE download Created with Sketch. 137.91KB
RAC Race Executes Key Contract for Israel Phase 2 AML Trial
08/06/21PRICE SENSITIVE download Created with Sketch. 59.49KB
RAC Contract to Commence Phase 2 Extramedullary AML Trial
02/06/21PRICE SENSITIVE download Created with Sketch. 122.87KB
RAC Prospectus
05/05/21PRICE SENSITIVE download Created with Sketch. 420.89KB
RAC Race investor briefing & updated presentation
05/05/21PRICE SENSITIVE download Created with Sketch. 7.51MB
RAC Placement closes oversubscribed-Bonus Option Issue launched
05/05/21PRICE SENSITIVE download Created with Sketch. 333.71KB
RAC Trading Halt
03/05/21PRICE SENSITIVE download Created with Sketch. 181.01KB
RAC Race Initiates Heart Safety Preclinical Study for Bisantrene
28/04/21PRICE SENSITIVE download Created with Sketch. 313.1KB
RAC Quarterly Activity Report & Appendix 4C
27/04/21PRICE SENSITIVE download Created with Sketch. 222.27KB
RAC Second independent study shows Bisantrene inhibits FTO
15/04/21PRICE SENSITIVE download Created with Sketch. 106.83KB
RAC Race Strategic Update March 2021
31/03/21PRICE SENSITIVE download Created with Sketch. 248.9KB
RAC Race Initiates Extramedullary AML Preclinical Study
30/03/21PRICE SENSITIVE download Created with Sketch. 112.93KB
RAC Race Initiates FTO Directed Kidney Cancer Preclinical Study
25/03/21PRICE SENSITIVE download Created with Sketch. 111.89KB
RAC Race Initiates FTO Melanoma Preclinical Study
19/03/21PRICE SENSITIVE download Created with Sketch. 114.1KB
RAC S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21PRICE SENSITIVE download Created with Sketch. 183.24KB
RAC Compelling Preclinical Breast Cancer Results
09/03/21PRICE SENSITIVE download Created with Sketch. 1.27MB
RAC Appendix 4D & Half-Year Financial Statements
25/02/21PRICE SENSITIVE download Created with Sketch. 972.04KB
RAC Quarterly Activity Report & Appendix 4C
27/01/21PRICE SENSITIVE download Created with Sketch. 242.62KB
(20min delay)
Last
$1.19
Change
-0.030(2.46%)
Mkt cap ! $197.8M
Open High Low Value Volume
$1.20 $1.24 $1.17 $25.43K 21.19K

Buyers (Bids)

No. Vol. Price($)
1 700 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.19 2856 1
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
$1.19
  Change
-0.030 ( 1.25 %)
Open High Low Volume
$1.18 $1.24 $1.18 8334
Last updated 15.37pm 06/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.